This inventor holds 15 USPTO granted patents and 16 published patent applications and 8 EPO patents. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Université Paris Descartes. Active years: 2014-2026.
Company Filing History:
14 out of 1,853 
10 out of 5,383 
8 out of 132 
Years Active: 2014-2026
Sure, here is the article about inventor Olivier Hermine:
Title: Innovator Spotlight: Olivier Hermine - Pioneering Treatments for Diseases
Introduction:
Olivier Hermine is a distinguished inventor based in Paris, France, with a remarkable record of 13 patents to his name. His groundbreaking research has focused on developing innovative methods and pharmaceutical compositions for the treatment of various diseases, particularly those mediated by the NRP-1/OBR complex signaling pathway and mast cell diseases.
Latest Patents:
Hermine's latest patents showcase his expertise in novel treatment approaches:
1. Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway: Hermine's invention revolves around administering antagonists of the NRP-1/OBR signaling pathway to treat diseases such as cancers, obesity, anorexia, autoimmune diseases, and infectious diseases.
2. Methods and pharmaceutical compositions for the treatment of mast cell diseases: Hermine's research demonstrates the efficacy of Hedgehog inhibitors in treating mast cell diseases by inhibiting proliferation and inducing apoptosis of mast cells.
Career Highlights:
Hermine has made significant contributions to the field of medical research through his work at renowned institutions. He has worked at the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Santé et de la Recherche Médicale (INSERM), where his innovative discoveries have advanced the healthcare industry.
Collaborations:
Throughout his career, Hermine has collaborated with esteemed professionals in the field, including Jean-Benoit Arlet and Flavia Guillem. These collaborations have led to the development of cutting-edge treatments and therapies for complex diseases.
Conclusion:
In conclusion, Olivier Hermine's dedication to revolutionizing healthcare through innovative treatments for diseases mediated by specific signaling pathways and mast cell disorders has positioned him as a leading figure in the industry. His patents and research contributions continue to inspire advancements in medical science, benefiting patients worldwide.